文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

呼吸机类型与SARS-CoV2感染危重症患者院内死亡率的相关性:一项前瞻性研究

Association of ventilator type with hospital mortality in critically ill patients with SARS-CoV2 infection: a prospective study.
PubMed 文献 · Ann Intensive Care · 2022-02-08
一句话结论在COVID-19相关ARDS有创通气患者中,使用非ICU涡轮式转运呼吸机的过渡ICU管理与标准ICU管理相比,院内死亡率、有创通气时长和ICU住院时长均无显著差异。

这项法国单中心前瞻性观察研究纳入2020年3月至2021年7月因确诊COVID-19相关ARDS入住大学附属三级医院ICU并全部插管的连续成人患者189例(男性140例,74.1%),中位年龄65岁(IQR 55-73),61例(32.3%)院内死亡。按使用ICU呼吸机还是较简易的涡轮式转运呼吸机分为两组,Cox多因素分析显示院内死亡相关因素为年龄≥70岁(HR 2.11;95%CI 1.24-3.59;P=0.006)、免疫缺陷(HR 2.43;95%CI 1.16-5.09;P=0.02)和血清肌酐≥100 µmol/L(HR 3.01;95%CI 1.77-5.10;P<0.001),呼吸机类型无关联。过渡ICU组与常规ICU组的有创机械通气时长(18天[IQR 11-32] vs 21天[13-37],P=0.39)和ICU住院时长(24天[IQR 14-40] vs 27天[15-44],P=0.44)均无显著差异。作者认为,研究设计不足以证明结局差异,但调整后结果未提示在COVID-19激增期间用此类转运呼吸机替代ICU呼吸机存在危害信号。

要点

  • 189例COVID-19相关ARDS插管患者中61例(32.3%)院内死亡,呼吸机类型(ICU呼吸机 vs 涡轮式转运呼吸机)与院内死亡无关联。
  • 院内死亡独立相关因素:年龄≥70岁(HR 2.11;95%CI 1.24-3.59;P=0.006)、免疫缺陷(HR 2.43;95%CI 1.16-5.09;P=0.02)、血清肌酐≥100 µmol/L(HR 3.01;95%CI 1.77-5.10;P<0.001)。
  • 过渡ICU(配备非ICU涡轮式呼吸机)与常规ICU(配备ICU及麻醉呼吸机)相比,有创机械通气时长18天(IQR 11-32) vs 21天(IQR 13-37),P=0.39。
  • 过渡ICU与常规ICU的ICU住院时长24天(IQR 14-40) vs 27天(IQR 15-44),P=0.44。
  • 作者认为,研究设计不足以证明结局差异,但调整后结果未提示COVID-19激增期间以转运呼吸机替代ICU呼吸机存在危害信号。

适用人群与场景

  • 2020年3月至2021年7月法国大学附属三级医院ICU连续纳入的成人COVID-19相关ARDS患者,全部接受有创机械通气。

研究设计与关键结果

  • 单中心前瞻性观察研究,纳入189例(男性140例,74.1%),中位年龄65岁(IQR 55-73),61例(32.3%)院内死亡。
  • 按呼吸机类型分组:ICU呼吸机(常规ICU,配备ICU及麻醉呼吸机) vs 较简易涡轮式转运呼吸机(过渡ICU,配备非ICU涡轮式呼吸机)。
  • Cox多因素分析:年龄≥70岁 HR 2.11(95%CI 1.24-3.59;P=0.006);免疫缺陷 HR 2.43(95%CI 1.16-5.09;P=0.02);血清肌酐≥100 µmol/L HR 3.01(95%CI 1.77-5.10;P<0.001);呼吸机类型无关联。
  • 有创机械通气时长:过渡ICU组18天(IQR 11-32) vs 常规ICU组21天(IQR 13-37),P=0.39。
  • ICU住院时长:过渡ICU组24天(IQR 14-40) vs 常规ICU组27天(IQR 15-44),P=0.44。

证据类型、等级与局限

  • 证据类型:单中心前瞻性观察研究。
  • 局限:作者指出研究设计不足以证明结局差异。

对床旁实践的改变

  • 作者认为,在COVID-19激增期间,使用转运型呼吸机作为ICU呼吸机的替代方案未显示危害信号,但研究设计不足以证明结局差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: To evaluate the association between ventilator type and hospital mortality in patients with acute respiratory distress syndrome (ARDS) related to COVID-19 (SARS-CoV2 infection), a single-center prospective observational study in France.

RESULTS: We prospectively included consecutive adults admitted to the intensive care unit (ICU) of a university-affiliated tertiary hospital for ARDS related to proven COVID-19, between March 2020 and July 2021. All patients were intubated. We compared two patient groups defined by whether an ICU ventilator or a less sophisticated ventilator such as a sophisticated turbine-based transport ventilator was used. Kaplan-Meier survival curves were plotted. Cox multivariate regression was performed to identify associations between patient characteristics and hospital mortality. We included 189 patients (140 [74.1%] men) with a median age of 65 years [IQR, 55-73], of whom 61 (32.3%) died before hospital discharge. By multivariate analysis, factors associated with in-hospital mortality were age ≥ 70 years (HR, 2.11; 95% CI, 1.24-3.59; P = 0.006), immunodeficiency (HR, 2.43; 95% CI, 1.16-5.09; P = 0.02) and serum creatinine ≥ 100 µmol/L (HR, 3.01; 95% CI, 1.77-5.10; P < 0.001) but not ventilator type. As compared to conventional ICU (equipped with ICU and anesthesiology ventilators), management in transient ICU (equipped with non-ICU turbine-based ventilators) was associated neither with a longer duration of invasive mechanical ventilation (18 [IQR, 11-32] vs. 21 [13-37] days, respectively; P = 0.39) nor with a longer ICU stay (24 [IQR, 14-40] vs. 27 [15-44] days, respectively; P = 0.44).

CONCLUSIONS: In ventilated patients with ARDS due to COVID-19, management in transient ICU equipped with non-ICU sophisticated turbine-based ventilators was not associated with worse outcomes compared to standard ICU, equipped with ICU ventilators. Although our study design is not powered to demonstrate any difference in outcome, our results after adjustment do not suggest any signal of harm when using these transport type ventilators as an alternative to ICU ventilators during COVID-19 surge.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Ferré A, Marquion F, Delord M, et al. Association of ventilator type with hospital mortality in critically ill patients with SARS-CoV2 infection: a prospective study. Ann Intensive Care. 2022. PMID: 35133543. doi:10.1186/s13613-022-00981-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。